Up a level |
Stohr, Wolfgang, Dunn, David T, Arenas-Pinto, Alejandro, Orkin, Chloe, Clarke, Amanda, Williams, Ian, Johnson, Margaret, Beeching, Nicholas J ORCID: 0000-0002-7019-8791, Wilkins, Edmund, Sanders, Karen et al (show 1 more authors)
(2016)
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy.
AIDS, 30 (17).
pp. 2617-2624.
Paton, Nicholas I, Stöhr, Wolfgang, Arenas-Pinto, Alejandro, Clarke, Amanda, Williams, Ian, Johnson, Margaret, Orkin, Chloe, Chen, Fabian, Lee, Vincent, Winston, Alan et al (show 5 more authors)
(2024)
Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT).
EClinicalMedicine, 69.
p. 102457.
Mbisa, Jean L, Ledesma, Juan, Kirwan, Peter, Bibby, David F, Manso, Carmen, Skingsley, Andrew, Murphy, Gary, Brown, Alison, Dunn, David T, Delpech, Valerie et al (show 1 more authors)
(2020)
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK.
The Journal of antimicrobial chemotherapy, 75 (11).
pp. 3311-3318.
Geretti, Anna Maria ORCID: 0000-0002-3670-6588, White, Ellen, Orkin, Chloe, Tostevin, Anna, Tilston, Peter, Chadwick, David, Leen, Clifford, Sabin, Caroline, Dunn, David T and UK HIV Drug Resistance Database and UK CHIC Study,
(2018)
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.
The Journal of antimicrobial chemotherapy, 74 (3).
pp. 746-753.